Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
Is a |
Compound barbiturates |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
Is a |
Product containing amobarbital (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Barbiturate sedative (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amobarbital (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
Is a |
Amylobarbitone sodium+quinalbarbitone sodium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amylobarbitone sodium - chemical |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Secobarbital (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amobarbital sodium (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Secobarbital sodium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
Has manufactured dose form |
A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Amylobarbitone sodium+quinalbarbitone sodium 50mg/50mg capsule (substance) |
Has manufactured dose form |
Oral capsule |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|